Mission Statement

The main specialty of the PharmacoInformatics group is the development and application of pharmacoinformatic methods in the field of drug Discovery and Development. We have long experience in the building of quantitative structure activity relationships (QSAR) methods and the development of new molecular descriptors (e.g. GRIND) as well as the development and implementation of computational approaches (e.g. ADAN, eTOXlab). Our group has also experience in scientific software development and has created original solutions for the deployment of self-contained prediction models in corporate environments. In the last years we have participated in some of the most important European projects in toxicology, gaining a unique experience in the application of computational approaches in safety assessment in the pharmaceutical area and in eco-toxicity.